Kenneth Edward Palmer

Director and Professor

University of Louisville

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kenneth Edward Palmer serves as the Director at the University of Louisville, USA. His research focuses on immunology and infectious diseases, particularly in relation to SARS-CoV-2 and COVID-19 vaccination effects. Recent articles highlight his work on mucosal immune responses, chronic ethanol consumption impacts, and innovative approaches to disease surveillance and prophylaxis.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (10)

Rachel J. Keith

University of Louisville

UNITED STATES

View details

Nir Drayman

Assistant Professor

University of California, Irvine

UNITED STATES

View details

University of Louisville School of Medicine

UNITED STATES

View details

Jiapeng Huang

Professor and Vice Chairman

University of Louisville

UNITED STATES

View details

Leslie Wolf

Clinical Asst Professor/Lab Director

University of Louisville

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kenneth Edward Palmer

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection

Mucosal and Serum Neutralization Immune Responses Elicited by COVID-19 mRNA Vaccination in Vaccinated and Breakthrough-Infection Individuals: A Longitudinal Study from Louisville Cohort

Impact of chronic ethanol consumption and SARS-COV-2 on the liver and intestine: A pilot dose-response study in mice.

Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin

Mo1536 ENDOGENOUS ENRICHMENT IN OMEGA 3 FATTY ACIDS ATTENUATED LIVER INJURY CAUSED BY CHRONIC ETHANOL CONSUMPTION AND SARS-COV-2 INFECTION IN MICE

Dynamic SARS-CoV-2 surveillance model combining seroprevalence and wastewater concentrations for post-vaccine disease burden estimates

Using SARS-CoV-2 Antibody Testing in COVID-19 Research

Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)

Stratified Simple Random Sampling Versus Volunteer Community-Wide Sampling for Estimates of COVID-19 Prevalence.

A topical rectal douche product containing Q-Griffithsin does not disrupt the epithelial border or alter CD4<sup>+</sup> cell distribution in the human rectal mucosa.

CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology.

Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.

Novel Antifungal Activity of Q-Griffithsin, a Broad-Spectrum Antiviral Lectin.

Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12.

Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention.

In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.

Rapid detection of SARS-CoV-2 antibodies using electrochemical impedance-based detector.

Stability of plasmid and viral banks supporting the cGMP manufacture of Q-Griffithsin from a TMV-based viral vector.

Collaborators (10)

Rachel J. Keith

Nir Drayman

Alok Amraotkar

Mukesh Sriwastva

Enya Qing

Elizabeth Cash

Richa Singhal

Joongho Joh

Jiapeng Huang

Leslie Wolf

Make your next move.